Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
IMTX
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -13.8%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
immatics
nasdaq
revenue
announced
offering
close
clinical
prame
cancer
price
cell
last
after
nyse
estimates
ended
hold
2023
trading
gained
IMTX
Immatics N.V. Ordinary Shares
StonvexStonvexStonvexStonvex